Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Roberto Bruno Bossio"'
Autor:
Emanuele D’Amico, Aurora Zanghì, Graziella Callari, Giovanna Borriello, Antonio Gallo, Giusi Graziano, Paola Valentino, Maria Buccafusca, Salvatore Cottone, Giuseppe Salemi, Paolo Ragonese, Roberto Bruno Bossio, Renato Docimo, Luigi Maria Edoardo Grimaldi, Carlo Pozzilli, Gioacchino Tedeschi, Mario Zappia, Francesco Patti
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 11 (2018)
Background: The aim of the study was to evaluate the achievement of ‘no evidence of disease activity’ (NEDA) over a 12-month period in a large multicenter population with relapsing remitting multiple sclerosis (RRMS) treated with delayed-release
Externí odkaz:
https://doaj.org/article/ea659756a85e48639b4ea0e198c780dc
Autor:
Silvia Messina, Claudio Solaro, Isabella Righini, Roberto Bergamaschi, Simona Bonavita, Roberto Bruno Bossio, Vincenzo Brescia Morra, Gianfranco Costantino, Paola Cavalla, Diego Centonze, Giancarlo Comi, Salvatore Cottone, Maura Chiara Danni, Ada Francia, Alberto Gajofatto, Claudio Gasperini, Mauro Zaffaroni, Loredana Petrucci, Elisabetta Signoriello, Giorgia Teresa Maniscalco, Gabriella Spinicci, Manuela Matta, Massimiliano Mirabella, Graziella Pedà, Letizia Castelli, Marco Rovaris, Edoardo Sessa, Daniele Spitaleri, Damiano Paolicelli, Alfredo Granata, Mario Zappia, Francesco Patti, SA.FE. study group
Publikováno v:
PLoS ONE, Vol 12, Iss 8, p e0180651 (2017)
The approval of Sativex for the management of multiple sclerosis (MS) spasticity opened a new opportunity to many patients. In Italy, the healthcare payer can be fully reimbursed by the involved pharma company with the cost of treatment for patients
Externí odkaz:
https://doaj.org/article/708f45afdbee4c38ad1ddae8ac4f4507
Publikováno v:
Computers, Vol 6, Iss 4, p 30 (2017)
Multiple sclerosis (MS) is a chronic demyelinating autoimmune disease affecting the central nervous system. One of its manifestations concerns impaired speech, also known as dysarthria. In many cases, a proper speech evaluation can play an important
Externí odkaz:
https://doaj.org/article/8fc48db7921d4352b0be85e6970ecfde
Autor:
Domenico Ippolito, Giorgia Teresa Maniscalco, Damiano Paolicelli, Daniele Spitaleri, Francesco Patti, Gianfranco Costantino, Margherita Russo, Clara Grazia Chisari, Letizia Castelli, Giovanna Salamone, Roberto Bruno Bossio, Maria Trotta, Claudio Solaro, Eliana Berra, Roberta Lanzillo, Elisabetta Signoriello, Raffaella Cerqua, Isabella Righini, Fabio Buttari, Gabriella Spinicci, Loredana Petrucci, Angelica Guareschi, Manuela Matta, Mario Zappia, Simona Pontecorvo, Maria Donata Benedetti, Paola Cavalla, Assunta Bianco, Claudio Gasperini, Eleonora Tavazzi, Francesco Saccà, Mauro Zaffaroni
Publikováno v:
Neurological Sciences. 41:2905-2913
Introduction: The approval of 9-δ-tetrahydocannabinol (THC)+cannabidiol (CBD) oromucosal spray (Sativex®) in Italy as an add-on medication for the management of moderate to severe spasticity in multiple sclerosis (MS) has provided a new opportunity
Autor:
Domenico Mirarchi, Pierangelo Veltri, Giuseppe Tradigo, Nicola Lombardo, Roberto Bruno Bossio, Patrizia Vizza, Gennarina Arabia, Aldo Quattrone
Publikováno v:
International Journal of Medical Informatics. 122:45-54
Background and objective Neurodegenerative diseases are disorders that affect neurons in the brain resulting in a debilitating condition and progressive degeneration of nerve cells. These diseases involve different aspects among which speech impairme
Autor:
Maria Tiziana Corasaniti, Stefano Tamburin, Giorgio Sandrini, Giacinto Bagetta, Roberto Bruno Bossio, Paolo Tonin, Luigi Antonio Morrone, Marilù Vulnera, Damiana Scuteri, Brunella Piro
Publikováno v:
European Journal of Clinical Pharmacology
Purpose Data concerning the number of diagnoses and of the drugs prescribed to patients affected by dementia are still scarce. Here we test whether or not (1) prescription of symptomatic drugs against Alzheimer’s disease (AD) may approximate the nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea27dc62c4b472291bd1ea6b13872a5
http://hdl.handle.net/11562/1025003
http://hdl.handle.net/11562/1025003
Autor:
Damiano Paolicelli, Assunta Bianco, Simona Pontecorvo, Paola Valentino, Elisabetta Capello, Roberta Lanzillo, M. Danni, Alberto Gajofatto, Gianfranco Costantino, Claudio Solaro, Roberto Bruno Bossio, Daniele Spitaleri, Giacomo Lus, Simona Bonavita, Mauro Zaffaroni, Pasquale Annunziata, Edoardo Sessa, Roberto Bergamaschi, Claudio Gasperini, Letizia Castelli, Diego Centonze, Salvatore Cottone, Loredana Petrucci, Vincenzo Brescia Morra, Marco Rovaris, Mario Zappia, Paola Cavalla, Angelica Guareschi, Gabriella Spinicci, Isabella Righini, Francesco Patti, Giorgia Teresa Maniscalco, Manuela Matta, Federica Esposito, Clara Grazia Chisari
IntroductionDelta-δ-tetrahydrocannabinol and cannabidiol (THC:CBD) oromucosal spray is used as an add-on therapy option for moderate to severe multiple sclerosis (MS) spasticity resistant to other medications. Aims of this study were to provide real
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c0984396a016f283708bfddc82f43f
http://hdl.handle.net/20.500.11769/463260
http://hdl.handle.net/20.500.11769/463260
Autor:
Valeria Saccà 1, Alessia Sarica 2, Fabiana Novellino 2, Stefania Barone 3, Tiziana Tallarico 3, Enrica Filippelli 3, Alfredo Granata 3, Carmelina Chiriaco 2, Roberto Bruno Bossio 4, Paola Valentino 3, Aldo Quattrone 2, 3
Publikováno v:
Brain imaging and behavior
13 (2019): 1103–1114. doi:10.1007/s11682-018-9926-9
info:cnr-pdr/source/autori:Valeria Saccà 1, Alessia Sarica 2, Fabiana Novellino 2, Stefania Barone 3, Tiziana Tallarico 3, Enrica Filippelli 3, Alfredo Granata 3, Carmelina Chiriaco 2, Roberto Bruno Bossio 4, Paola Valentino 3, Aldo Quattrone 2,3/titolo:Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data./doi:10.1007%2Fs11682-018-9926-9/rivista:Brain imaging and behavior (Print)/anno:2019/pagina_da:1103/pagina_a:1114/intervallo_pagine:1103–1114/volume:13
13 (2019): 1103–1114. doi:10.1007/s11682-018-9926-9
info:cnr-pdr/source/autori:Valeria Saccà 1, Alessia Sarica 2, Fabiana Novellino 2, Stefania Barone 3, Tiziana Tallarico 3, Enrica Filippelli 3, Alfredo Granata 3, Carmelina Chiriaco 2, Roberto Bruno Bossio 4, Paola Valentino 3, Aldo Quattrone 2,3/titolo:Evaluation of machine learning algorithms performance for the prediction of early multiple sclerosis from resting-state FMRI connectivity data./doi:10.1007%2Fs11682-018-9926-9/rivista:Brain imaging and behavior (Print)/anno:2019/pagina_da:1103/pagina_a:1114/intervallo_pagine:1103–1114/volume:13
Machine Learning application on clinical data in order to support diagnosis and prognostic evaluation arouses growing interest in scientific community. However, choice of right algorithm to use was fundamental to perform reliable and robust classific
Autor:
Pierangelo Veltri, Giuseppe Tradigo, Domenico Mirarchi, Maria Redavide, Patrizia Vizza, Roberto Bruno Bossio
Publikováno v:
ICCS
Multiple Sclerosis (MS) is one of the most common neurodegenerative disorder that presents specific manifestations among which the impaired speech (known also as dysarthria). The evaluation of the speech plays a crucial role in the diagnosis and foll
Autor:
Mario Zappia, Giuseppe Salemi, Graziella Callari, Mariangela Sciandra, L.M.E. Grimaldi, G. Tedeschi, Antonio Gallo, Carlo Pozzilli, Roberto Bruno Bossio, Salvatore Cottone, Giovanna Borriello, Francesco Patti, Aurora Zanghì, Emanuele D'Amico, Maria Buccafusca, Paola Valentino
Teriflunomide (TRF) and Dimethyl fumarate (DMF) are licensed drugs for relapsing-remitting Multiple Sclerosis (RRMS). We aimed to compare the rate and the time to discontinuation among persons with RRMS (pwRRMS), newly treated with TRF and DMF. A ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb808452d454fec6a3a0bff16aeeda2c
http://hdl.handle.net/20.500.11769/360473
http://hdl.handle.net/20.500.11769/360473